LORAZEPAM INJECTION USP
LORAZEPAM INJECTION USP
Discontinued
DIN Number
02438704
Drug Class
Human
Market Date
Nov 12, 2015
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02438704
AIG Number0110731002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA06 LORAZEPAM
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
,
Intravenous
AHFS Classification28:24.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
LORAZEPAMActive
Strength: 2 MG / ML
Monograph: LORAZEPAM